Off topic respond:
NTII has Dynorphin A, a peptide analog of the human
endorphins. Not from frog and very safe, already tested at a phase I study.
No respiratory problems, no toxic problems. And it works.
Problem it is a peptide, needs to be injected intravenously, other
delivery sytem could be imagine: nasal, lungs, transcutaneous, oral with
antienzymatic protection....
2nd problem, the company has no money to comercially develop the drug.
They are trying to sublicense it.
3rd problem, it is not easy, neither inexpensive to manufacture, case
of many peptide compounds like insulin,epogen,bpi. NTII does not have this
manufacturing ability.
No wonder the stock price is approximately $1.
If the frog drug is oral, they have an advantage.
Morphine is very cheap, and very effective, but side effects are the
problem.
The frog drug is not addictive? being a nicotine receptor stimulant is
a little difficult not to be, but biochemistry can bring surprises. |
